prof. dr. Chris Verhofstede
- Work address
-
C. Heymanslaan 10, ingang 22 - verdieping 2
9000 Gent - Chris.Verhofstede@UGent.be
- ORCID iD
-
0000-0002-0645-1174
Show
Sort by
-
- Journal Article
- A1
- open access
Prevalence and evolution of transmitted human immunodeficiency virus drug resistance in Belgium between 2013 and 2019
-
- Journal Article
- A1
- open access
Impact of COVID-19 on the Belgian HIV epidemic : slowdown of HIV transmission and testing and adaptation of care
-
Screening algorithms for HBV, HCV, HIV and syphilis in an anatomical donation program
-
Benefits of antiretroviral therapy initiation during acute HIV infection
-
High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing
-
Chronic and early antiretroviral therapy impact Human Immunodeficiency Virus (HIV) serological assay sensitivity, leading to more false-negative test results in HIV diagnosis
-
- Journal Article
- A1
- open access
Piloting a surveillance system for HIV drug resistance in the European Union
-
- Journal Article
- A1
- open access
Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital
-
- Journal Article
- A1
- open access
Predominance of the heterozygous CCR5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface
-
- Journal Article
- A1
- open access
Exploring HIV-1 transmission dynamics by combining phylogenetic analysis and infection timing